Inactive

The Clinical Trials Unit of the U.S. Naval Medical and Research Unit No. 6 (NAMRU-6) is seeking to procure 46( box of 10) of Southern Hemisphere Fluad Quadrivalent Prefilled Syringes as the enhanced v... The Clinical Trials Unit of the U.S. Naval Medical and Research Unit No. 6 (NAMRU-6) is seeking to procure 46( box of 10) of Southern Hemisphere Fluad Quadrivalent Prefilled Syringes as the enhanced vaccine that will be evaluated against standard-dose influenza vaccine in our protocol: Randomized Controlled Trial, Double Blind, Phase III, To Evaluate The Immunogenicity of an Adjuvanted Influenza Vaccine among Health Care Personnel (Educate) The adjuvanted influenza vaccine has proven to be safe and more immunogenic than the standard-dose vaccine and it is currently licensed for people aged 65 years and older in the US. Through this randomized clinical trial, we will examine the immunogenic performance of the adjuvanted-influenza vaccine in comparison to the standard-dose vaccine (SD), among healthcare personnel, particularly among those who responded poorly to standard vaccination.